Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Clinical trial NCT04402970 · COMPLETED
Trial details
- NCT number
- NCT04402970
- Sponsor
- University of Missouri-Columbia
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2020-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.